Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Fu Wang

Showing results (61-70 of 150) with videos related to

Pageof 15
Sort By:
Ebiomedicine|November 10, 2022
Hearing impairment is associated with cognitive decline, brain atrophy and tau pathologyHui-Fu Wang, Wei Zhang, Edmund T Rolls, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2014
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysisHui-Fu Wang, Jin-Tai Yu, Shao-Wen Tang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 27, 2023
Associations of blood cell indices and anemia with risk of incident dementia: A prospective cohort study of 313,448 participantsYi-Xuan Qiang, Yue-Ting Deng, Ya-Ru Zhang, et al.
Journal of Alzheimer'S Disease : JAD|March 26, 2014
Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysisChen-Chen Tan, Jin-Tai Yu, Hui-Fu Wang, et al.
Journal of Alzheimer'S Disease : JAD|October 26, 2020
PET Amyloid and Tau Status Are Differently Affected by Patient FeaturesMeng-Shan Tan, Yu-Xiang Yang, Hui-Fu Wang, et al.
Oncotarget|May 14, 2016
Impact of SORL1 genetic variations on MRI markers in non-demented eldersRui-Hua Yin, Jun Li, Lin Tan, et al.
Journal of Alzheimer'S Disease : JAD|August 13, 2014
Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysisMeng-Shan Tan, Jin-Tai Yu, Chen-Chen Tan, et al.
Molecular Neurobiology|August 31, 2014
Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral IschemiaXi-Chen Zhu, Teng Jiang, Qiao-Quan Zhang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 2, 2020
Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementiaXue-Ning Shen, Jie-Qiong Li, Hui-Fu Wang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2015
Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: a systematic review and meta-analysis of cohort studiesJie-Qiong Li, Lan Tan, Hui-Fu Wang, et al.
Pageof 15

Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
Ebiomedicine|November 10, 2022
Hearing impairment is associated with cognitive decline, brain atrophy and tau pathologyHui-Fu Wang, Wei Zhang, Edmund T Rolls, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2014
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysisHui-Fu Wang, Jin-Tai Yu, Shao-Wen Tang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 27, 2023
Associations of blood cell indices and anemia with risk of incident dementia: A prospective cohort study of 313,448 participantsYi-Xuan Qiang, Yue-Ting Deng, Ya-Ru Zhang, et al.
Journal of Alzheimer'S Disease : JAD|March 26, 2014
Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysisChen-Chen Tan, Jin-Tai Yu, Hui-Fu Wang, et al.
Journal of Alzheimer'S Disease : JAD|October 26, 2020
PET Amyloid and Tau Status Are Differently Affected by Patient FeaturesMeng-Shan Tan, Yu-Xiang Yang, Hui-Fu Wang, et al.
Oncotarget|May 14, 2016
Impact of SORL1 genetic variations on MRI markers in non-demented eldersRui-Hua Yin, Jun Li, Lin Tan, et al.
Journal of Alzheimer'S Disease : JAD|August 13, 2014
Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysisMeng-Shan Tan, Jin-Tai Yu, Chen-Chen Tan, et al.
Molecular Neurobiology|August 31, 2014
Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral IschemiaXi-Chen Zhu, Teng Jiang, Qiao-Quan Zhang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 2, 2020
Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementiaXue-Ning Shen, Jie-Qiong Li, Hui-Fu Wang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2015
Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: a systematic review and meta-analysis of cohort studiesJie-Qiong Li, Lan Tan, Hui-Fu Wang, et al.
Pageof 15